These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 24916890)

  • 21. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
    Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
    J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating tumor cells count predicts survival in colorectal cancer patients.
    Romiti A; Raffa S; Di Rocco R; Roberto M; Milano A; Zullo A; Leone L; Ranieri D; Mazzetta F; Medda E; Sarcina I; Barucca V; D'Antonio C; Durante V; Ferri M; Torrisi MR; Marchetti P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):279-84. PubMed ID: 25267956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients with metastatic breast cancer leading to CD4+ T cell lymphopaenia have poor outcome.
    Trédan O; Manuel M; Clapisson G; Bachelot T; Chabaud S; Bardin-dit-Courageot C; Rigal C; Biota C; Bajard A; Pasqual N; Blay JY; Caux C; Ménétrier-Caux C
    Eur J Cancer; 2013 May; 49(7):1673-82. PubMed ID: 23265706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subsite heterogeneity in the profiles of circulating cytokines in colorectal cancer.
    Krzystek-Korpacka M; Zawadzki M; Kapturkiewicz B; Lewandowska P; Bednarz-Misa I; Gorska S; Witkiewicz W; Gamian A
    Cytokine; 2018 Oct; 110():435-441. PubMed ID: 29801973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiplex analysis of blood cytokines as a prognostic tool in HIV related non-Hodgkin lymphoma patients: a potential role of interleukin-7.
    Bortolin MT; Tedeschi R; Bidoli E; Zanussi S; Pratesi C; Vaccher E; Tirelli U; De Paoli P
    Cytokine; 2012 Oct; 60(1):90-5. PubMed ID: 22795293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of inflammatory cytokines in the progression of colorectal cancer.
    Chung YC; Chang YF
    Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
    Efficace F; Innominato PF; Bjarnason G; Coens C; Humblet Y; Tumolo S; Genet D; Tampellini M; Bottomley A; Garufi C; Focan C; Giacchetti S; Lévi F;
    J Clin Oncol; 2008 Apr; 26(12):2020-6. PubMed ID: 18421055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukocyte mitochondrial DNA content: a novel biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Qu F; Chen Y; Wang X; He X; Ren T; Huang Q; Zhang J; Liu X; Guo X; Gu J; Xing J
    Carcinogenesis; 2015 May; 36(5):543-52. PubMed ID: 25823896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
    Golan T; Urban D; Berger R; Lawrence YR
    Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of serum microRNA-21 in colorectal cancer.
    Menéndez P; Padilla D; Villarejo P; Palomino T; Nieto P; Menéndez JM; Rodríguez-Montes JA
    J Surg Oncol; 2013 Nov; 108(6):369-73. PubMed ID: 23970420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating Inflammatory Mediators as Potential Prognostic Markers of Human Colorectal Cancer.
    Di Caro G; Carvello M; Pesce S; Erreni M; Marchesi F; Todoric J; Sacchi M; Montorsi M; Allavena P; Spinelli A
    PLoS One; 2016; 11(2):e0148186. PubMed ID: 26859579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
    Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
    J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of patients with high-risk lymph node-negative colorectal cancer and potential benefit from adjuvant chemotherapy.
    Oñate-Ocaña LF; Montesdeoca R; López-Graniel CM; Aiello-Crocifoglio V; Mondragón-Sánchez R; Cortina-Borja M; Herrera-Goepfert R; Oros-Ovalle C; Gallardo-Rincón D
    Jpn J Clin Oncol; 2004 Jun; 34(6):323-8. PubMed ID: 15333684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
    Rich T; Innominato PF; Boerner J; Mormont MC; Iacobelli S; Baron B; Jasmin C; Lévi F
    Clin Cancer Res; 2005 Mar; 11(5):1757-64. PubMed ID: 15755997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is primary tumour resection associated with survival improvement in patients with colorectal cancer and unresectable synchronous metastases? A pooled analysis of individual data from four randomised trials.
    Faron M; Pignon JP; Malka D; Bourredjem A; Douillard JY; Adenis A; Elias D; Bouché O; Ducreux M
    Eur J Cancer; 2015 Jan; 51(2):166-76. PubMed ID: 25465185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival.
    Lévi F; Dugué PA; Innominato P; Karaboué A; Dispersyn G; Parganiha A; Giacchetti S; Moreau T; Focan C; Waterhouse J; Spiegel D;
    Chronobiol Int; 2014 Oct; 31(8):891-900. PubMed ID: 24927369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated leukocyte cell adhesion molecule (CD166)--its prognostic power for colorectal cancer patients.
    Tachezy M; Zander H; Gebauer F; Marx A; Kaifi JT; Izbicki JR; Bockhorn M
    J Surg Res; 2012 Sep; 177(1):e15-20. PubMed ID: 22482754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS).
    Marschner N; Frank M; Vach W; Ladda E; Karcher A; Winter S; Jänicke M; Trarbach T
    Colorectal Dis; 2019 Jul; 21(7):816-826. PubMed ID: 30834622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.